The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease. [electronic resource]
Producer: 20130510Description: 345-61 p. digitalISSN:- 1753-4666
- Animals
- Bronchodilator Agents -- adverse effects
- Delayed-Action Preparations
- Dry Powder Inhalers
- Humans
- Muscarinic Antagonists -- adverse effects
- Pulmonary Disease, Chronic Obstructive -- drug therapy
- Receptor, Muscarinic M3 -- antagonists & inhibitors
- Scopolamine Derivatives -- adverse effects
- Tiotropium Bromide
- Tropanes -- adverse effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.